Oncosil Medical Ltd
ASX:OSL

Watchlist Manager
Oncosil Medical Ltd Logo
Oncosil Medical Ltd
ASX:OSL
Watchlist
Price: 1.04 AUD Market Closed
Market Cap: 19.7m AUD

Net Margin
Oncosil Medical Ltd

-1 196.8%
Current
-1 864%
Average
1%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-1 196.8%
=
Net Income
-15.1m
/
Revenue
1.3m

Net Margin Across Competitors

No Stocks Found

Oncosil Medical Ltd
Glance View

OncoSil Medical Ltd. develops and commercializes neurology services, including those for pancreatic cancer. The company is headquartered in North Sydney, New South Wales. The company went IPO on 2005-08-15. The firm is focused on unresectable locally advanced pancreatic cancer (LAPC). The firm's lead product, OncoSil, is a single-use brachytherapy internal radiation device used to deliver a pre-determined dose of beta radiation directly into cancerous tissue. The OncoSil consists of microparticles that contain a radioisotope phosphorous-32 and a formulated diluent, which acts as a carrier to facilitate the implantation of the microparticles into the target tissue. The company enables doctors to target a greater radiation dose directly to the tumor, while sparing surrounding critical organs. The OncoSil device is used for the treatment of unresectable LAPC and is used in conjunction with chemotherapy.

OSL Intrinsic Value
0.44 AUD
Overvaluation 58%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-1 196.8%
=
Net Income
-15.1m
/
Revenue
1.3m
What is the Net Margin of Oncosil Medical Ltd?

Based on Oncosil Medical Ltd's most recent financial statements, the company has Net Margin of -1 196.8%.

Back to Top